Ethnic disparity in chemotherapy–induced febrile neutropenia incidence in Asian breast cancer patients: A retrospective cohort study

Author:

Lim Zi Lin1,Ho Peh Joo1,Hartman Mikael2,Tan Ern Yu3,Riza Nur Khaliesah Binte Mohamed4,Lim Elaine Hsuen5,Nitar Phyu5,Wong Fuh Yong5,Li Jingmei1

Affiliation:

1. Genome Institute of Singapore

2. National University Hospital

3. Tan Tock Seng Hospital

4. Saw Swee Hock School of Public Health

5. National Cancer Centre Singapore

Abstract

Abstract Background Majority of published findings on chemotherapy–induced febrile neutropenia (FN) are restricted to three ethnic groups: Asians, Caucasians, and African Americans. In this two–part study, we examined FN incidence and risk factors in Chinese, Malay and Indian chemotherapy–treated breast cancer (BC) patients in Southeast Asia. Methods Hospital records or ICD codes (fever:ICD9/10:2880/D70 and neutropenia:ICD9/10:7806/R509) were used to identify patients with FN, during or within 30 days from the last chemotherapy session. In both Singapore Breast Cancer Cohort (SGBCC) and Joint Breast Cancer Registry (JBCR), time to first FN from start of chemotherapy was estimated using Cox regression. Multinomial regression was used to evaluate differences in patient, tumour, and treatment characteristics across ethnicities. Results FN was observed in 170 of 1,014 patients (16.7%) in SGBCC. Cox model showed that non–Chinese were at higher risk of developing FN (HRMalay[95% CI]:2.04[1.44–2.88], p < 0.001; HRIndian:1.88[1.11–3.18], p = 0.018). In JBCR, FN was observed in 965 of 7449 patients (13.0%). Indian patients, lower baseline absolute neutrophil count, non– luminal A proxy subtypes, and anthracycline–containing regimens were identified as risk factors for FN in the univariable Cox models. Disparities across ethnicities risk (HRMalay: 1.29 [1.07–1.54], p = 0.006; HRIndian: 1.50 [1.19–1.88], p < 0.001) remained significant even after further adjustments. Finally, age–adjusted multinomial model showed that as compared to Chinese patients, non–Chinese (ORMalay vs Chinese(ref):3.65[1.45–9.16],p = 0.006;ORIndian vs Chinese(ref):4.43[1.45–13.60],p = 0.009) were significantly more likely to develop multiple episodes of FN during treatment. Conclusion Ethnic differences in chemotherapy–induced FN among BC patients exist. Further studies can focus on investigating pharmacogenetic differences across ethnicities.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3